From Pathogen to Infectious Disease Diagnosis

Accurate, rapid diagnostics capable of distinguishing Ebola from other febrile illnesses are essential to controlling the ongoing Bundibugyo Ebola outbreak, with BioFire Defense deploying its Global Fever Special Pathogens Panel to affected regions in partnership with local governments. Chuck Cooper, MD, chief medical officer at bioMérieux, offers some insights on this testing platform. 

A new multiplex blood-screening assay is streamlining transfusion safety by enabling simultaneous detection and discrimination of HIV, HBV, HCV, and hepatitis E in a single test, helping laboratories improve efficiency, reduce turnaround times, and strengthen blood supply resilience amid ongoing donation and staffing shortages. Nico Michel, PhD, of Roche Diagnostics, offers insights on this diagno...

Artificial intelligence is increasingly reshaping clinical decision-making, and a new generation of point-of-care tools is targeting one of healthcare’s most persistent challenges: antimicrobial stewardship. In a recent podcast discussion, Eolas Medical Founder and CEO Declan Kelly, MBBS, outlined how limited access to localized guidelines has historically hindered optimal prescribing. As a former...